## Abstract In order to clarify the cellular tropism of human T‐cell leukemia virus type I (HTLV‐I) and the effects of HTLV‐I infection on T‐cell functions, we investigated the infectiousness of HTLV‐I on T cells bearing T‐cell receptor (TCR) γδ and functional alterations of the HTLV‐I‐infected TCR
Mode of transmission of human T-cell leukemia virus type I (HTLV I) in a human promyelocytic leukemia HL60 cell
✍ Scribed by K. Hiramatsu; M. Masuda; H. Yoshikura
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- French
- Weight
- 1004 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
HTLV-I propagated in lMR9O human diploid fibroblasts was transmitted to human myeloid leukemia HL60 cells at a low efficiency. After co-cultivation for 3 months, the viral genome was detected in 14/48 HL60 cell clones. Among the 14 HTLV-I-infected clones, 8 contained subgenomic fragments alone or in addition to the complete HTLV-I genome. The frequency of deleted proviruses (9/24 total proviruses) was unexpectedly high. Hirt's supernatant of some of the clones harboring complete HTLV-I genome@) in the chromosome contained both linear and circular HTLV-I proviral DNAs. The circular DNAs were composed of one LTR and 2 LTR closed circular proviruses. These clones produced infectious HTLV-I constitutively, which was proved by transmission of the viral genome into fresh lMR9O cells by co-cultivation. However, in these clones, re-integration of extrachromo-soma1 provirus into their own chromosomes was not observed.
'To whom reprint requests should be sent.
📜 SIMILAR VOLUMES
## Abstract A rabbit lymphoid cell line (Ra‐I) was established by co‐cultivation with a human T‐cell line (MT‐2) carrying human T‐cell leukemia virus (HTLV). The Ra‐l cell line is chromosomally male and is persistently infected with HTLV. Ra‐l cells, with or without mitomycin‐C treatment, were inoc
## Abstract The prevalence of HTLV‐I antibodies was evaluated in Jamaica among persons with various malignant, infectious, autoimmune and hematologic disorders and in clinically normal persons. Results document that: (1) the prevalence of HTLV‐I antibodies in this population increases with age; (2)